CORC

在结果中检索

CORC

浏览/检索结果: 共90条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：14/0  |  提交时间：2023/11/10
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study 期刊论文
LEUKEMIA, 2020
作者:  Yang, Yong;  Wang, Ying;  Liu, Xin;  He, Xia;  Zhang, Li-Ling
收藏  |  浏览/下载：109/0  |  提交时间：2020/11/30
Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11
作者:  Liu, Yi-Zhen;  Bi, Lan-Qing;  Chang, Gui-Lin;  Guo, Ye;  Sun, Si
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2019, 卷号: 11, 页码: 4243-4254
作者:  Zhou, Xiangxiang;  Sun, Xiaogang;  Zhao, Wenbo;  Fang, Xiaosheng;  Wang, Xin
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/11
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG) 期刊论文
2019, 卷号: 11
作者:  Liu Wei-Xin;  Shi Mei;  Su Hang;  Wang Ying;  He Xia
收藏  |  浏览/下载：47/0  |  提交时间：2020/01/03
Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era 期刊论文
2019, 页码: 1-10
作者:  Qi Fei;  Chen Bo;  Wang Jingjing;  Lin Xinyi;  Qi Shunan
收藏  |  浏览/下载：17/0  |  提交时间：2020/01/03
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG) 期刊论文
2019, 页码: 1-10
作者:  Qi Shu-Nan;  Xu Li-Ming;  Yuan Zhi-Yong;  Wu Tao;  Zhu Su-Yu
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma 期刊论文
NATURE MEDICINE, 2018, 卷号: 24, 页码: 154-+
作者:  Wen, Haijun;  Ma, Huajuan;  Cai, Qichun;  Lin, Suxia;  Lei, Xinxing
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/02
Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma 期刊论文
Nature Medicine, 2018, 卷号: Vol.24 No.2, 页码: 154-164
作者:  Wen, H.;  Ma, H.;  Cai, Q.;  Lin, S.;  Lei, X.
收藏  |  浏览/下载：14/0  |  提交时间：2019/02/25
CD30 expression and survival in extranodal NK/T-cell lymphoma: A systematic review and meta-analysis 期刊论文
Oncotarget, 2018, 卷号: Vol.9 No.23, 页码: 16547-16556
作者:  Chen, Z.;  Guan, P.;  Shan, T.;  Ye, Y.;  Gao, L.
收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace